Nikhil Lalwani

CIK: 0001822629

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (33.3%)

Position reduction

Option Exercises (M)1 (4.8%)

Derivative conversions

Awards (A)3 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)10 (47.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANIP

ANI PHARMACEUTICALS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (21 total)

ANIP
ANI PHARMACEUTICALS INC
Oct 15, 2026
Sale(S)
Direct
5.4K shares at avg. $71.89$388K
ANIP
ANI PHARMACEUTICALS INC
Sep 15, 2026
Sale(S)
Direct
5.4K shares at avg. $71.00$383K
ANIP
ANI PHARMACEUTICALS INC
Aug 25, 2026
Sale(S)
Direct
5.4K shares at avg. $74.30$401K
ANIP
ANI PHARMACEUTICALS INC
May 11, 2026
Sale(S)
Direct
55K shares at avg. $77.57$4.3M
ANIP
ANI PHARMACEUTICALS INC
Mar 7, 2026
Tax Payment(F)
Direct
17.1K shares at avg. $74.04$1.3M
ANIP
ANI PHARMACEUTICALS INC
Feb 28, 2026
Tax Payment(F)
Direct
12.2K shares at avg. $73.90$903K
ANIP
ANI PHARMACEUTICALS INC
Feb 26, 2026
Award(A)
Direct
75.6K shares at avg. $77.15$5.8M
ANIP
ANI PHARMACEUTICALS INC
Feb 14, 2026
Tax Payment(F)
Direct
10.3K shares at avg. $77.36$797K
ANIP
ANI PHARMACEUTICALS INC
Feb 12, 2026
Tax Payment(F)
Direct
11.7K shares at avg. $76.70$896K
ANIP
ANI PHARMACEUTICALS INC
Feb 11, 2026
Tax Payment(F)
Direct
30.7K shares at avg. $76.25$2.3M
ANIP
ANI PHARMACEUTICALS INC
Aug 12, 2025
Sale(S)
Direct
57K shares at avg. $85.93$4.9M
ANIP
ANI PHARMACEUTICALS INC
Mar 23, 2025
Tax Payment(F)
Direct
17.5K shares at avg. $64.26$1.1M
ANIP
ANI PHARMACEUTICALS INC
Mar 7, 2025
Tax Payment(F)
Direct
17.1K shares at avg. $60.62$1.0M
ANIP
ANI PHARMACEUTICALS INC
Feb 28, 2025
Tax Payment(F)
Direct
12.2K shares at avg. $61.89$756K
ANIP
ANI PHARMACEUTICALS INC
Feb 14, 2025
Tax Payment(F)
Direct
7.8K shares at avg. $58.92$460K
ANIP
ANI PHARMACEUTICALS INC
Feb 12, 2025
Award(A)
Direct
60.9K shares-
ANIP
ANI PHARMACEUTICALS INC
Feb 12, 2025
Award(A)
Direct
91.4K shares-
ANIP
ANI PHARMACEUTICALS INC
Nov 26, 2024
Sale(S)
Direct
30K shares at avg. $57.95$1.7M
ANIP
ANI PHARMACEUTICALS INC
Nov 26, 2024
Sale(S)
Direct
3.5K shares at avg. $58.30$203K
ANIP
ANI PHARMACEUTICALS INC
Nov 26, 2024
Exercise(M)
Direct
30K shares at avg. $29.00$870K
ANIP
ANI PHARMACEUTICALS INC
Sep 8, 2024
Tax Payment(F)
Direct
3.6K shares at avg. $60.51$221K

		Type	Shares	Price		Ownership
Oct 15, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	5,400	$71.89	$388,206	Direct
Sep 15, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	5,400	$71.00	$383,400	Direct
Aug 25, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	5,400	$74.30	$401,220	Direct
May 11, 2026	ANIP ANI PHARMACEUTICALS INC	Sale(S)	55,000	$77.57	$4,266,350	Direct
Mar 7, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	17,060	$74.04	$1,263,122	Direct
Feb 28, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	12,217	$73.90	$902,836	Direct
Feb 26, 2026	ANIP ANI PHARMACEUTICALS INC	Award(A)	75,592	$77.15	$5,831,923	Direct
Feb 14, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	10,298	$77.36	$796,653	Direct
Feb 12, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	11,688	$76.70	$896,470	Direct
Feb 11, 2026	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	30,659	$76.25	$2,337,749	Direct
Aug 12, 2025	ANIP ANI PHARMACEUTICALS INC	Sale(S)	56,960	$85.93	$4,894,573	Direct
Mar 23, 2025	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	17,455	$64.26	$1,121,658	Direct
Mar 7, 2025	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	17,060	$60.62	$1,034,177	Direct
Feb 28, 2025	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	12,216	$61.89	$756,048	Direct
Feb 14, 2025	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	7,799	$58.92	$459,517	Direct
Feb 12, 2025	ANIP ANI PHARMACEUTICALS INC	Award(A)	60,932	-	-	Direct
Feb 12, 2025	ANIP ANI PHARMACEUTICALS INC	Award(A)	91,399	-	-	Direct
Nov 26, 2024	ANIP ANI PHARMACEUTICALS INC	Sale(S)	30,000	$57.95	$1,738,500	Direct
Nov 26, 2024	ANIP ANI PHARMACEUTICALS INC	Sale(S)	3,481	$58.30	$202,942	Direct
Nov 26, 2024	ANIP ANI PHARMACEUTICALS INC	Exercise(M)	30,000	$29.00	$870,000	Direct
Sep 8, 2024	ANIP ANI PHARMACEUTICALS INC	Tax Payment(F)	3,646	$60.51	$220,619	Direct

1-21 of 21 transactions

About Lalwani Nikhil

Lalwani Nikhil (SEC CIK 0001822629) files insider reports with the SEC as PRESIDENT & CEO of ANI PHARMACEUTICALS INC (ANIP).

Signal8 holds 15 ownership filings by Lalwani Nikhil, all Form 4s, filed between Sep 10, 2024 and Oct 16, 2026. Those filings report 21 transactions, from Sep 8, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lalwani Nikhil's filings is in PRINCETON, NJ.

Recent filings by Lalwani Nikhil

Oct 15, 2026: Open-market sale of ANIP shares (Form 4, code S).
Sep 15, 2026: Open-market sale of ANIP shares (Form 4, code S).
Aug 25, 2026: Open-market sale of ANIP shares (Form 4, code S).
May 11, 2026: Open-market sale of ANIP shares (Form 4, code S).
Mar 7, 2026: Tax withholding of ANIP shares (Form 4, code F).

Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)

CAREY STEPHEN P., SVP & CFO
Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
Thoma Jeanne, Director
Gosebruch Henry O, Director
Gutwerg Ori, SVP, GENERICS
TANNENBAUM RENEE P, Director

How to read Form 4 transaction codes